-
HypoRT with Concurrent Chemo Shows Favorable Safety Profile
Dr. Nan Bi said further investigation of HypoRT with immunotherapy is warranted based on these findings and potential immune-sparing benefits.
More News from #WCLC25
-
New Data Warrant Broader Lung Cancer Screening Guidelines
Dr. Elaine Shum said the FANSS trial data confirm the feasibility of expanding screening to high-risk individuals with no smoking history.
-
Survival Benefit Found in Screening Surgically Fit Patients Up to Age 80
Findings from Dr. Patrick Goodley suggest that older patients who can undergo surgery may achieve survival benefits similar to younger patients.